Rationale for using nitric oxide donor therapy for prevention of bone loss and treatment of osteoporosis in humans

Annals of the New York Academy of Sciences

Volumn 1117, Issue , 2007, Pages 283-297

  Wimalawansa, Sunil J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

cGMP; Estrogen; Menopause; Nitric oxide synthase inhibitors; Nitroglycerine; Novel therapies; OPG; Osteopenia; RANKL; SERM

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN; CALCIUM; CONJUGATED ESTROGEN; CYCLIC GMP; ESTRADIOL; ESTROGEN; FLUORIDE; GLYCERYL TRINITRATE; HORMONE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; OSTEOCLAST DIFFERENTIATION FACTOR; PLACEBO; RALOXIFENE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TRANSCRIPTION FACTOR RUNX2; TRIAMCINOLONE ACETONIDE; VITAMIN D;

ANGINA PECTORIS; BONE ATROPHY; BONE DENSITOMETRY; BONE DISEASE; BONE METABOLISM; BONE REMODELING; BREAST CANCER; CELL COMMUNICATION; CELL FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ESTROGEN THERAPY; EVENING DOSAGE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; ISOPRENYLATION; METABOLIC REGULATION; MORBIDITY; MORNING DOSAGE; MORTALITY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; REGULATORY MECHANISM; STROKE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 36549054084     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.066     Document Type: Conference Paper

References (50)

1. MONCADA, S., R.M.J. PALMER & C.A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142.
2. IGNARRO, L.J., G.M. BUGA, K.S. WOOD, et al. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-9269.
3. MONCADA, S. & C.A. HIGGS. The L-arginine: nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012.
4. BRUNORI, M., A. GIUFFRE, P. SARTI, et al. 1999. Nitric oxide and cellular respiration. Cell Mol. Life Sci. 56: 549-557.
5. ROSSELLI, M., B. IMTHURN, P.J. KELLER, et al. 1994. Circulating nitrite/nitrate levels increases with follicular development: indirect evidence for estradiol-mediated NO release. Biochem. Biophys. Res. Commun. 202: 1543-1552.
6. STACY, E., P. KORKIA, M.V.J. HUKKANEN, et al. 1998. Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J. Clin. Endocrinol. Metab. 83: 3056-3061.
7. ROSSELLI, M., B. IMTHURN, P.J. KELLER, et al. 1995. Circulating nitric oxide (nitrite/ nitrate) levels in postmenopausal women substituted with 17B-estradiol and norethisterone acetate. Hypertension 25: 848-853.
8. WIMALAWANSA, S.J., G. DEMARCO, P. GANGULA & C. YALLAMPALLI. 1996. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18: 301-304.
9. MORIMOTO, L.M., E. WHITE, Z. CHEN, et al. 2002. Obesity, body size, and risk of postmenopausal breast cancer: The Women's Health Initiative. Cancer Causes Control 13: 741-751.
10. HSIA, J., G. HEISS, H. REN, et al., For the Women's Health Initiative Investigators. 2007. Calcium/vitamin d supplementation and cardiovascular events. Circulation 115: 846-854.
11. WIMALAWANSA, S.J. 2000. Nitroglycerine therapy is as effective as standard estrogen replacement therapy (premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J. Bone Miner. Res. 15: 2240-2244.
12. WIMALAWANSA, S.J. In vivo and in vitro effects of nitric oxide donor, nitroglycerine on bone. J. Musculoskeleta Interact. (In press).
13. Consensus Development Conference. 2001. Diagnosis, osteoporosis prevention, and therapy. JAMA 285: 785-795.
14. SILVERTON, S.F., O.A. ADEBANJO, B.S. MOONGA, et al. 1999. Direct microsensor measurement of nitric oxide production by the osteoclast. Biochem. Biophys. Res. Commun. 259(1): 73-77.
15. KASTEN, T.P., P. COLLIN-OSDOBY, N. PATEL, et al. 1994. Potentiation of osteoclastic bone resorbing activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91: 3569-3573.
16. LOWIK, C.W.G.M., P.H. NIBBERING, M. VAN DER RUIT & S.E. PAPAPOULOS. 1994. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J. Clin. Invest. 93: 1465-1472.
17. KIKKAWA, I., S. SAITO, K. TOMINAGA, et al. 1998. Related articles, links. lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts (OCL) in murine bone marrow cell culture. Microbiol. Immunol. 42: 591-598.
18. BROULIK, P.D., M. HALUZIK & J. SKRHA. 2003. The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes. Physiol. Res. 52: 729-734.
19. RALSTON, S.H., D. TODD, M.H. HELFRICH, et al. 1994. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336.
20. HUKKANEN, M., F.J. HUGHES, L.D.K. BUTTERY, et al. 1995. Cytokine-stimulated expression of nitric oxide synthase by mouse, rat and human osteoblast-like cells and its functional role in osteoblast metabolism. Endocrinology 136: 5445-5453.
21. OELZNER, P. & G. HEIN. 1997. Inflammation and bone metabolism in rheumatoid arthritis. Patho-genetic viewpoints and therapeutic possibilities [Review]. Medizinische Klinik 92: 607-614.
22. MACINTYRE I., M. ZAIDI, A.A.S.M. TOWHIDUL, et al. 1991. Osteoclast inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA 88: 2936-2940.
23. ARMOUR, K.E., R.J. VAN'T HOF, P.S. GRABOWSKI, et al. 1999. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J. Bone Miner. Res. 14: 2137-2142.
24. VAN'T HOF, R.J. & S.H. RALSTON. 2001. Nitric oxide and bone [Review]. Immunology 103: 255-261.
25. FINI, M., P. TORRICELLI, G. GIAVARESI, et al. 2001. Effect of L-lysine and L-arginine on primary osteoblast cultures from normal and osteopenic rats. Biomed. Pharmacother. 55: 213-220.
26. AGUIRRE, J., L. BUTTERY, M. O'SHAUGHNESSY, et al. 2001. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am. J. Pathol. 158: 247-257.
27. PITSILLIDES, A.A., S.C.F. RAWLINSON, R.F.L. SUSWULLO, et al. 1995. Mechanical strain-induced NO production by bone cells: a possible role in adaptive bone (re)modeling. FASEB J. 9: 1614-1622.
28. TURNER, C.H., Y. TAKANO, I OWAN & G.A. MURRELL. 1996. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am. J. Physiol. 270: E634-E639.
29. WIMALAWANSA, S.M., T. CHAPPA, L. FANG, et al. 2000. Frequency-dependent effect of nitric oxide donor nitroglycerine on bone. J. Bone. Miner. Res. 15: 1119-1125.
30. WIMALAWANSA, S.J. 2000. Restoration of ovariectomy-induced bone loss by nitroglycerine. Calcif. Tiss. Int. 66: 56-60.
31. WIMALAWANSA, S.J., M.T. CHAPA, C. YALLAMPALLI, et al. 1997. Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerine in male rats. Bone 21: 275-280.
32. GARRETT, I.R., G. GUTIERREZ & G.R. MUNDY. 2004. Statins and bone formation [Review]. Pharma. Design 7: 715-736.
33. ROGERS, M.J., K.M. CHILTON, F.P. COXON, et al. 1996. Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. J. Bone Miner. Res. 11: 1482-1491.
34. ZOFKOVA, I. & R.L. KANCEVA. 1997. New drugs with positive effects on bones [Review]. Casopis Lekaru Ceskych 136: 459-463.
35. LEE, S.K., H. HUANG, S.W. LEE, et al. 2004. Related articles, links. involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp. Cell. Res. 298: 359-368.
36. BRANDI, M.L., M. HUKKANEN, T. UMEDA, et al. 1995. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc. Natl. Acad. Sci. USA 92: 2954-2958.
37. STERCK, J.G., J. KLEIN-NULEND, P. LIPS & E.H. BURGER. 1998. Response of normal and osteoporotic human bone cells to mechanical stress in vitro. Am. J. Physiol. 274: E1113-E1120.
38. JAMAL, S., G. MILANI, R. LIPSCHUTZ, et al. 1997. The therapeutic use of nitrates does not influence postmenopausal osteoporosis. J. Bone. Miner. Res. 12(Suppl 1): S229.
39. PUNJABI, C.J., D.L. LASKIN, D.E. HECK & J.D. LASKIN. 1992. Production of nitric oxide by murine bone marrow cells. J. Immunol. 149: 2179-2184.
40. BURGER, E.H. & J. KLEIN-NULEN. 1999. Responses of bone cells to biomechanical forces in vitro [Review]. Adv. Dental Res. 13: 93-98.
41. EVANS, D.M. & S.H. RALSTON. 1996. Nitric oxide and bone [Review]. J. Bone Miner. Res. 11: 300-305.
42. KAWASE, T., G.A. HOWARD, B.A. ROOS & D.M. BURNS. 1993. Nitric oxide stimulates mineralization in osteoblastic cell cultures. J. Bone Miner. Res. 8: S372.
43. VISSER, J.J. & K. EKMAN. 1994. Aginine supplementation in the prevention and treatment of osteoporosis. Med. Hypotheses. 43: 339-342.
44. ARMOUR, K.J., K.E. ARMOUR, R.J. VAN'T HOF, et al. 2001. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblastapoptosis. Arthritis Rheumat. 44: 2790-2796.
45. ARMOUR, K.E. & S.H. RALSTON. 1998. Estrogen up-regulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139: 799-802.
46. WIMALAWANSA, S.J. Nitric oxide: a new class of drugs for multiple disorders. Exp. Opin. Pharmacother. (in press).
47. GRIMES, J.P., A. WILSON, G. ROJO & S. WIMALAWANSA. 2005. Risk factors associated with low vitamin D levels in postmenopausal women. Baseline analysis of NOVEL clinical study. Natl. Osteoporos. Found. Ann. Meet. (Abst.)
48. WIMALAWANSA, S.J., 1988. Ph.D. Thesis. Calcitonin gene-related peptide: isolation, distribution and receptor binding. University of London.
49. WIMALAWANSA, D.M., S.M. WIMALAWANSA, C. YALLAMPALLI & S.J. WIMALAWANSA. Enhancement of bone mineral density with the combination of therapy with nitric oxide donors and bisphosphonates. Calcif. Tiss. Int. (In press).
50. MARTIN, T.J., N.A. SIMS. 2005. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11: 76-81.